pharmacopeial requirements and patient safety.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) and Quality Control (QC) departments for testing benzyl alcohol as a preservative in injectable drug products, including multi-dose vials and prefilled syringes.

3. Responsibilities

• Analytical Scientist: Develops and validates the method, prepares standard and sample solutions, and performs analysis.
• QC Analyst: Conducts routine testing of benzyl alcohol content using the validated method.
• QA Executive: Ensures review, approval, and regulatory compliance of testing reports.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring accurate and validated detection of benzyl alcohol in injectable pharmaceutical products.

5. Procedure

5.1 Sample Preparation

1. Withdraw 1 mL of the parenteral formulation into a 10 mL volumetric flask.
2. Dilute to volume with mobile phase (e.g., water:acetonitrile = 70:30).
3. Filter using a 0.45 µm membrane filter before HPLC analysis.

5.2 Standard Preparation

1. Prepare a primary stock solution of benzyl alcohol at 1 mg/mL using mobile phase.
2. Prepare working standards in the range of 10–100 µg/mL for calibration.

5.3 Chromatographic Conditions

• Column: C18, 250 mm × 4.6 mm, 5 µm
• Mobile Phase: Water:Acetonitrile (70:30 v/v)
• Flow Rate: 1.0 mL/min
• Detection Wavelength: 210 nm
• Injection Volume: 20 µL

5.4 System Suitability

1. Inject six replicates of standard solution.
2. % RSD of peak area should be ≤ 2.0%
3. Tailing factor should be ≤ 2.0

5.5 Quantification

1. Inject standard and sample solutions.
2. Calculate concentration using linear regression equation from calibration curve.
3. Express results in mg/mL or % w/v based on labeled strength.

5.6 Acceptance Criteria

• Benzyl alcohol content should be within 90%–110% of labeled amount.
• No interfering peaks near retention time of benzyl alcohol.

5.7 Method Validation Parameters

1. Specificity: Should distinguish benzyl alcohol from formulation excipients.
2. Linearity: r² ≥ 0.999 between 10–100 µg/mL.
3. Accuracy: Recovery should be between 98%–102% at three levels (80%, 100%, 120%).
4. Precision: % RSD ≤ 2.0%
5. LOD/LOQ: Based on signal-to-noise ratio of 3:1 and 10:1, respectively.

6. Abbreviations

• HPLC: High Performance Liquid Chromatography
• LOD: Limit of Detection
• LOQ: Limit of Quantification
• RSD: Relative Standard Deviation
• QA: Quality Assurance

7. Documents

1. Benzyl Alcohol Test Log – Annexure-1
2. Chromatogram Report Set – Annexure-2
3. Method Validation Summary – Annexure-3

8. References

• USP <561>: Articles of Botanical Origin (for preservative guidelines)
• ICH Q2(R1): Validation of Analytical Procedures
• FDA Guidance on Multidose Injection Formulations

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name	Meghna Joshi	Vikram Das	Sunita Reddy
Designation	Analytical Chemist	QA Reviewer	Head – AMD
Department	Analytical Method Development	QA	Analytical Method Development

11. Annexures

Annexure-1: Benzyl Alcohol Test Log

Sample ID	Retention Time (min)	Assay (% w/v)	Label Claim (% w/v)	Status
BA-INJ-275-01	3.12	0.92%	0.90%	Pass

Annexure-2: Chromatogram Report Set

Overlay of chromatograms for standard and sample showing peak purity and consistent retention time of benzyl alcohol at 3.1 ± 0.1 min.

Annexure-3: Method Validation Summary

The developed method demonstrated high sensitivity, accuracy, and specificity for benzyl alcohol in parenteral dosage forms. All validation parameters met ICH Q2(R1) criteria. Suitable for release and stability analysis.

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
21/05/2025	2.0	Updated validation parameters and detection wavelength	Annual Review	Sunita Reddy
01/04/2022	1.0	Initial SOP Release	New SOP	QA Head